Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

October 1, 1987; Volume 139,Issue 7

ARTICLES

  • You have accessRestricted access
    Evidence that expression of asialo-GM1 may be associated with cell activation. Correlation of asialo-GM1 expression with increased total cellular RNA and protein content in normal thymocyte and spleen cell populations.
    R D Stout, G A Schwarting and J Suttles
    J Immunol October 1, 1987, 139 (7) 2123-2129;
  • You have accessRestricted access
    Immunosuppressive activity of T cell clones generated from human T cells stimulated with autologous TPHA cells.
    B Gulwani, M Maio, L Imberti, R J Melamede and S Ferrone
    J Immunol October 1, 1987, 139 (7) 2130-2136;
  • You have accessRestricted access
    Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    D L Thiele, J A Calomeni and P E Lipsky
    J Immunol October 1, 1987, 139 (7) 2137-2142;
  • You have accessRestricted access
    Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    M A Shipp and E L Reinherz
    J Immunol October 1, 1987, 139 (7) 2143-2148;
  • You have accessRestricted access
    The primary role of murine bone marrow in the production of natural killer cells. A cytokinetic study.
    S B Pollack and C Rosse
    J Immunol October 1, 1987, 139 (7) 2149-2156;
  • You have accessRestricted access
    Selective down modulation of L3T4 molecules on murine thymocytes by the tumor promoter, phorbol 12-myristate 13-acetate.
    P T Wang, M Bigby and M S Sy
    J Immunol October 1, 1987, 139 (7) 2157-2165;
  • You have accessRestricted access
    Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.
    P J Wettstein and M P Colombo
    J Immunol October 1, 1987, 139 (7) 2166-2171;
  • You have accessRestricted access
    Polyclonal activation of the murine immune system by an antibody to IgD. VIII. Stimulation of IgD secretion.
    J D Mountz, J Smith, C M Snapper, J F Mushinski and F D Finkelman
    J Immunol October 1, 1987, 139 (7) 2172-2178;
  • You have accessRestricted access
    Acquisition of an anti-idiotypic cytotoxic T lymphocyte repertoire in B cell-transferred or tetraparental bone marrow chimeric mice.
    H Yamamoto, S Bitoh and S Fujimoto
    J Immunol October 1, 1987, 139 (7) 2179-2186;
  • You have accessRestricted access
    Subpopulations of B lymphocytes in germinal centers.
    G Fyfe, J A Cebra-Thomas, E Mustain, J M Davie, C D Alley and M H Nahm
    J Immunol October 1, 1987, 139 (7) 2187-2194;
  • You have accessRestricted access
    The phenotype of thymocytes derived from a single clonogenic precursor.
    S Ezine, L Jerabek and I Weissman
    J Immunol October 1, 1987, 139 (7) 2195-2199;
  • You have accessRestricted access
    T cell lineages in the thymus of lpr/lpr mice. Evidence for parallel pathways of normal and abnormal T cell development.
    R C Budd, M Schreyer, G C Miescher and H R MacDonald
    J Immunol October 1, 1987, 139 (7) 2200-2210;
  • You have accessRestricted access
    Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin-2-producing, tolerogen-specific T lymphocytes.
    K M Mohler and J W Streilein
    J Immunol October 1, 1987, 139 (7) 2211-2219;
  • You have accessRestricted access
    Expression of carbohydrate differentiation antigens during ontogeny of the murine thymus.
    L Lefrancois
    J Immunol October 1, 1987, 139 (7) 2220-2229;
  • You have accessRestricted access
    Inhibition of antibodies to CD3 surface antigen and phytohemagglutinin-mediated T cellular responses by inhibiting Ca2+/phospholipid-dependent protein kinase activity with the aid of 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine dihydrochloride.
    A E Nel, I Schabort, A Rheeder, P Bouic and M W Wooten
    J Immunol October 1, 1987, 139 (7) 2230-2236;
  • You have accessRestricted access
    Prominent IgM rheumatoid factor production by human cord blood lymphocytes stimulated in vitro with Staphylococcus aureus Cowan I.
    A I Levinson, N F Dalal, M Haidar, L Tar and M Orlow
    J Immunol October 1, 1987, 139 (7) 2237-2241;
  • You have accessRestricted access
    Murine interstitial nephritis. VI. Characterization of the B cell response in anti-tubular basement membrane disease.
    M D Clayman, L Michaud and E G Neilson
    J Immunol October 1, 1987, 139 (7) 2242-2249;
  • You have accessRestricted access
    Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro.
    J A Hill, F Haimovici and D J Anderson
    J Immunol October 1, 1987, 139 (7) 2250-2254;
  • You have accessRestricted access
    Immunoregulation in the Peyer's patch microenvironment. Cellular basis for the enhanced responses by the B cells of X-linked immunodeficient CBA/N mice.
    J H Eldridge, K W Beagley and J R McGhee
    J Immunol October 1, 1987, 139 (7) 2255-2262;
  • You have accessRestricted access
    Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages.
    K Ljunggren, B Böttiger, G Biberfeld, A Karlson, E M Fenyö and M Jondal
    J Immunol October 1, 1987, 139 (7) 2263-2267;
  • You have accessRestricted access
    Phosphorylation of the CD8 antigen on cytotoxic human T cells in response to phorbol myristate acetate or antigen-presenting B cells.
    R B Acres, P J Conlon, D Y Mochizuki and B Gallis
    J Immunol October 1, 1987, 139 (7) 2268-2274;
  • You have accessRestricted access
    Rejection of fetal neocortical neural transplants by H-2 incompatible mice.
    M K Nicholas, J P Antel, K Stefansson and B G Arnason
    J Immunol October 1, 1987, 139 (7) 2275-2283;
  • You have accessRestricted access
    Similar in vivo expansion of B cells from normal DBA/2 and autoimmune NZB mice in xid recipients.
    D M Klinman and A D Steinberg
    J Immunol October 1, 1987, 139 (7) 2284-2289;
  • You have accessRestricted access
    Effect of B cell stimulatory factor-1 (interleukin 4) on Fc epsilon and Fc gamma receptor expression on murine B lymphocytes and B cell lines.
    D H Conrad, T J Waldschmidt, W T Lee, M Rao, A D Keegan, R J Noelle, R G Lynch and M R Kehry
    J Immunol October 1, 1987, 139 (7) 2290-2296;
  • You have accessRestricted access
    Interleukin 1 production by human lung tissue. I. Identification and characterization.
    B S Bochner, S D Landy, M Plaut, C A Dinarello and R P Schleimer
    J Immunol October 1, 1987, 139 (7) 2297-2302;
  • You have accessRestricted access
    Interleukin 1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids.
    B S Bochner, B K Rutledge and R P Schleimer
    J Immunol October 1, 1987, 139 (7) 2303-2307;
  • You have accessRestricted access
    A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
    Y Jacques, B Le Mauff, F Boeffard, A Godard and J P Soulillou
    J Immunol October 1, 1987, 139 (7) 2308-2316;
  • You have accessRestricted access
    Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts.
    E A Kurt-Jones, W Fiers and J S Pober
    J Immunol October 1, 1987, 139 (7) 2317-2324;
  • You have accessRestricted access
    Antigen-induced human interferon-gamma production. Differential dependence on interleukin 2 and its receptor.
    C D Kelly, K Welte and H W Murray
    J Immunol October 1, 1987, 139 (7) 2325-2328;
  • You have accessRestricted access
    A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1.
    E S Kleinerman, L B Lachman, R D Knowles, R Snyderman and G J Cianciolo
    J Immunol October 1, 1987, 139 (7) 2329-2337;
  • You have accessRestricted access
    Modulation of human natural killer cell cytotoxic activity, lymphokine production, and interleukin 2 receptor expression by thymic hormones.
    S A Serrate, R S Schulof, L Leondaridis, A L Goldstein and M B Sztein
    J Immunol October 1, 1987, 139 (7) 2338-2343;
  • You have accessRestricted access
    Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells.
    A Vazquez, M T Auffredou, J P Gerard, J F Delfraissy and P Galanaud
    J Immunol October 1, 1987, 139 (7) 2344-2348;
  • You have accessRestricted access
    Interleukin 4 enhances the ability of antigen-specific B cells to form conjugates with T cells.
    V M Sanders, R Fernandez-Botran, J W Uhr and E S Vitetta
    J Immunol October 1, 1987, 139 (7) 2349-2354;
  • You have accessRestricted access
    Reconstitution of a functional interleukin 2 receptor in a nonlymphoid cell.
    L A Rubin, G S Hoekzema, D L Nelson, W C Greene and G Jay
    J Immunol October 1, 1987, 139 (7) 2355-2360;
  • You have accessRestricted access
    Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation.
    M Lévi-Strauss and M Mallat
    J Immunol October 1, 1987, 139 (7) 2361-2366;
  • You have accessRestricted access
    Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
    M J Glennie, H M McBride, A T Worth and G T Stevenson
    J Immunol October 1, 1987, 139 (7) 2367-2375;
  • You have accessRestricted access
    Monoclonal antibodies to adenosine receptor by an auto-anti-idiotypic approach.
    H H Ku, W L Cleveland and B F Erlanger
    J Immunol October 1, 1987, 139 (7) 2376-2384;
  • You have accessRestricted access
    Complete variable region sequences of five homologous high affinity anti-digoxin antibodies.
    D J Panka and M N Margolies
    J Immunol October 1, 1987, 139 (7) 2385-2391;
  • You have accessRestricted access
    Beta-adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent upon the mechanism of cell activation.
    C P Nielson
    J Immunol October 1, 1987, 139 (7) 2392-2397;
  • You have accessRestricted access
    Biochemical and functional properties of serine esterases in acidic cytoplasmic granules of cytotoxic T lymphocytes.
    P A Henkart, G A Berrebi, H Takayama, W E Munger and M V Sitkovsky
    J Immunol October 1, 1987, 139 (7) 2398-2405;
  • You have accessRestricted access
    Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system.
    A el-Hag and R A Clark
    J Immunol October 1, 1987, 139 (7) 2406-2413;
  • You have accessRestricted access
    Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures.
    J M Carlin, E C Borden, P M Sondel and G I Byrne
    J Immunol October 1, 1987, 139 (7) 2414-2418;
  • You have accessRestricted access
    Pertussis toxin triggers rapid second messenger production in human T lymphocytes.
    P M Rosoff, R Walker and L Winberry
    J Immunol October 1, 1987, 139 (7) 2419-2423;
  • You have accessRestricted access
    Inhibition of human T lymphocyte E rosette formation by neutrophils and hydrogen peroxide. Differential sensitivity between helper and suppressor T lymphocytes.
    N D Staite, R P Messner and D C Zoschke
    J Immunol October 1, 1987, 139 (7) 2424-2430;
  • You have accessRestricted access
    Identification of variants of the basophilic leukemia (RBL-2H3) cells that have defective phosphoinositide responses to antigen and stimulants of guanosine 5'-triphosphate-regulatory proteins.
    E Woldemussie, H Ali, T Takaishi, R P Siraganian and M A Beaven
    J Immunol October 1, 1987, 139 (7) 2431-2438;
  • You have accessRestricted access
    Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures.
    F Bussolino, G Camussi, M Aglietta, P Braquet, A Bosia, G Pescarmona, F Sanavio, N D'Urso and P C Marchisio
    J Immunol October 1, 1987, 139 (7) 2439-2446;
  • You have accessRestricted access
    Characterization of serologic and cell-mediated reactivity of a 38-kDa antigen isolated from Mycobacterium tuberculosis.
    G V Kadival, S D Chaparas and D Hussong
    J Immunol October 1, 1987, 139 (7) 2447-2451;
  • You have accessRestricted access
    Suppressive substance produced by T cells from mice chronically infected with Trypanosoma cruzi. I. Preferential inhibition of the induction of delayed-type hypersensitivity.
    F Y Liew, M T Scott, D S Liu and S L Croft
    J Immunol October 1, 1987, 139 (7) 2452-2457;
  • You have accessRestricted access
    Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells.
    E A Ojo-Amaize, P Nishanian, D E Keith Jr, R L Houghton, D F Heitjan, J L Fahey and J V Giorgi
    J Immunol October 1, 1987, 139 (7) 2458-2463;
  • You have accessRestricted access
    Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    H Azuma, J D Phillips and W R Green
    J Immunol October 1, 1987, 139 (7) 2464-2473;
  • You have accessRestricted access
    Schistosoma mansoni polypeptides immunogenic in mice vaccinated with radiation-attenuated cercariae.
    J P Dalton and M Strand
    J Immunol October 1, 1987, 139 (7) 2474-2481;
  • You have accessRestricted access
    Anti-basement membrane glomerulopathy in experimental trypanosomiasis.
    J A Bruijn, B S Oemar, J H Ehrich, J M Foidart and G J Fleuren
    J Immunol October 1, 1987, 139 (7) 2482-2488;
  • You have accessRestricted access
    Mutant human B cell lines deficient in class II major histocompatibility complex transcription.
    A F Calman and B M Peterlin
    J Immunol October 1, 1987, 139 (7) 2489-2495;
  • You have accessRestricted access
    Relationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA autoantibodies.
    H Dersimonian, R S Schwartz, K J Barrett and B D Stollar
    J Immunol October 1, 1987, 139 (7) 2496-2501;
  • You have accessRestricted access
    Hyperthyroxinemic mice have reduced natural killer cell activity. Evidence for a defective trigger mechanism.
    J Stein-Streilein, M Zakarija, M Papic and J M McKenzie
    J Immunol October 1, 1987, 139 (7) 2502-2507;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 139, Issue 7
1 Oct 1987
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606